ARTESUNATE 60mg, powder,vial +NaHCO3 5% 1ml +NaCl 0.9% 5ml
STD
DINJARTS6V-
Valid Article
Account code:
60000
HS Code:
300460
Last Updated on:
02/05/2024, 22:03:57
6.5.3.1 - For curative treatment
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
P01BE03
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
The product is part of at least one Kit.
A kit is a collection of products (medical and/or logistic) that are needed for a certain intervention in emergency. The choice and quantity of the articles reflects the MSF protocols for this specific situation. The use of Kits allows to start an intervention without a detailed evaluation.
ARTESUNATE
Therapeutic Action
Antimalarial, artemisinine derivative
Indications
Severe malaria caused by Plasmodium falciparum
Instructions for use
Combi-pack containing two necessary diluents:
- 1 powder vial of 60 mg artesunate
- 1 ampoule containing 1 ml of 5% sodium bicarbonate (NaHCO3) for reconstitution
- 1 ampoule containing 5 ml of 0.9% NaCl for dilution
Reconstitute the powder vial and dilute the reconstituted solution following the GUIDELINES FOR ADMINISTRATION OF INJECTABLE ARTESUNATE
FOR SEVERE MALARIA (see articles related).
Must be given as slow IV injection (3 to 5 minutes) or slow IM injection.
Precautions for Use
Never administer by IV infusion.
Do not use water for injection for reconstitution of the artesunate powder. Use the ampoules of diluents provided.
Storage
- Below 25°C - Protect from sunlight
- After reconstitution, use the solution immediately.